Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Chitin and chitosan are useful in cosmetics for oral care, haircare, and skincare, including UV protection and strength improvement.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.

Keratin-based particles safely improve hair strength, smoothness, and heat protection.

Freeze-dried dexamethasone nanoparticles in a hydrogel are stable and effective for treating alopecia areata.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

Seaweeds contain beneficial compounds with potential uses in food, cosmetics, and health, but more research is needed to improve extraction and safety.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Injecting a special gel with human protein particles can help hair grow.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

The symposium concluded that understanding the molecular mechanisms of skin aging could lead to better clinical practices and treatments.

Several companies launched new hair care ingredients in 2011 to improve conditioning, color retention, combability, and heat protection.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Nanotechnology shows promise for better chronic wound healing but needs more research.

Future hair cosmetics will be safer and more effective.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Chitosan slows root hair growth and causes a buildup of callose at low concentrations, but at high concentrations, it only inhibits growth without callose buildup.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.